RNA Nanotherapeutics’ innovative solution is to develop cancer-targeting multifunctional RNA nanoparticles as the next generation cancer therapies with improved efficacy and minimal side effect. Scientists at RNA Nanotherapeutics have developed an innovative RNA-nanotechnology-based approach to specifically target a novel key therapy resistance gene in breast cancer to overcome treatment resistance. The team of RNA Nanotherapeutics is comprised of experienced professionals who are committed to providing better and safer treatments for cancer patients.
